Tumour Treating Fields – A new treatment for Glioblastoma

Tumour Treating Fields – A new treatment for Glioblastoma

Malignant gliomas (glioblastoma, GBM) are difficult to treat. Our current methods of treatment –  surgery, radiotherapy and chemotherapy – all help but are ultimately not curative. New treatments are desperately needed.


In recent years, a new form of treatment has been developed which may have a role in the future – Tumour Treating Fields (TTFields). TTFields are low intensity, intermediate frequency electric fields that slow cell division therefore inhibit tumour growth. This treatment was developed after it was shown that cancer cells in culture (i.e. in the laboratory) were stopped from dividing and then were killed by these electric currents. Animal models were then used to show a positive effect and the technology was then first used in patients with cancer less than 10 years ago.

novocure-cancer-cell2TTFields started to be used for brain cancer a short time after that. Now, 2 large international, multicentre trials have been published examining the effect of TTFields. The first trial examined whether there was a benefit in patients with recurrent or progressive GBM (EF-11 trial, Stupp et al., Eur J Cancer 2012). This group of patients have a notoriously difficult problem and very few options are available. TTFields do not seem to provide significant benefits in this group.

The EF-14 trial was an international randomized study for patients with newly diagnosed GBM (glioblastoma) comparing the outcomes of patients treated with standard post-radiotherapy chemotherapy to those who also had TTFields (Stupp et al., JAMA, 2015). There did appear to be some benefit – TTFields did appear to slow the tumour in some patients. Recurrence was delayed, and on average, overall survival was a little better (19.6 months vs 16.6 months). There are also valid criticisms to the design of this trial and it could be that other factors – rather than the TTFields themselves – were at play.

But even if TTFields were having some positive effect, they are not a magic cure. In the EF-14 trial, at 18 months after treatment, the tumour had recurred in about 80% of patients whether they had TTFields or not. Whilst overall survival was better at 2 years for the TTFields group, that benefit soon evaporated, and the survival rate did not seem to be any different by about 3 years. About 20% of all patients were still alive at 4 years – there was no benefit from TTFields by this point.

There is still a lot to learn about the possible role of TTFields and many trials are ongoing. I am not convinced that this form of treatment will play a major role in the future however.

By Prof David Walker, Neurosurgeon

Prof David Walker is a neurosurgeon and spinal surgeon at BrizBrain & Spine. He has a special clinical interest in brain tumours and is actively involved in conducting research to help find a cure for this disease. Prof Walker is  also the Managing Director of the Newro Foundation, a research organisation that conducts research into brain and spine conditions. 


Patient and staff safety is our highest priority at Briz Brain & Spine.

For patients with appointments, if you are suffering any symptoms such as fever, dry cough, sore throat, tiredness or shortness of breath or have recently travelled interstate, overseas or been in contact with someone who has returned from interstate or overseas, or have been in contact with a confirmed case of COVID-19, please contact our friendly reception team before attending the clinic. A telehealth appointment may be an alternative method of speaking with our surgeons.

Protecting the health of our staff is vital to ensure they can continue to provide great service.  Patients are encouraged to prepay accounts over the phone prior to appointments or via payWave or other contactless payment methods. Patients are also asked to complete the Patient Details Form and sign the Privacy Policy Agreement electronically prior to their appointment. These forms can be found under our Contacts page on the website or by clicking here. Please note, patients are asked to bring only ONE support person to their appointment and maintain appropriate social distances to help reduce the risk of Covid-19 transmission.

During this current outbreak of Covid-19 coronavirus we want to assure all of our patients that we will continue to implement procedures to maintain a hygienic clinical environment. This includes:

-          Disinfecting and wiping down all treatment surfaces

-          Regular cleaning of rooms and shared equipment

-          Thorough cleaning of all communal items including reception chairs, tables, door handles, pens and other shared items

-          All staff have access to infection control procedures and training to implement these as necessary

We are carefully monitoring the directions and advice of Queensland Health, the Australian Government Department of Health and the World Health Organization. In the meantime, it is still business as usual and our doors are open.

Briz Brain & Spine wishes to apologise for the inconvenience caused and thanks you for your cooperation and understanding during this unprecedented situation.